Exagen
In Brief This Week: CareDx; Centogene; Exagen; VolitionRx; More
News items for the week of March 10, 2025
Exagen Posts Flat to Slight Decline in Preliminary Q4 Report, Gets Conditional NY Approval
The company received conditional approval from New York state for its new systemic lupus erythematosus and rheumatoid arthritis biomarker assays.
Exagen Q3 Revenues Decline 7 Percent
The firm said its Q3 revenues were negatively impacted by $1.2 million in one-time adjustments.
In Brief This Week: Thermo Fisher Scientific, Labcorp, Personalis, Exagen, Co-Diagnostics, More
News items for the week of Aug. 5, 2024.
Earnings Roundup: Renalytix, DermTech, Oncocyte, Aspira Women's Health, Exagen, More
Renalytix, DermTech, Oncocyte, Aspira Women's Health, and others reported their first quarter earnings this week.
May 11, 2022
Exagen Q1 Revenues Drop 2 Percent
Nov 10, 2021
Exagen Q3 Revenues Rise 14 Percent
Oct 25, 2021
Exagen Enters $27.2M Debt Refinancing Agreement
Aug 9, 2021
Exagen Posts 43 Percent Increase in Q2 Revenues
May 11, 2021